Introduction: The Growing Challenge of Ventricular Tachycardia in Congenital Heart Disease
As surgical and medical management of congenital heart disease (CHD) has advanced, a growing population of adults with repaired or palliated CHD has emerged. However, this success brings a new set of clinical challenges, most notably the high prevalence of late-onset arrhythmias. Sustained monomorphic ventricular tachycardia (VT) is a significant cause of morbidity and sudden cardiac death in this population. Unlike VT in patients with ischemic cardiomyopathy, the substrate in CHD is uniquely complex, often characterized by heterogeneous scars from prior surgical incisions, patches, and the underlying congenital malformation itself.
Catheter ablation has become a cornerstone of VT management, yet success rates in CHD have historically lagged behind other etiologies. The primary obstacle is the three-dimensional complexity of the cardiac anatomy, which makes traditional electroanatomical mapping (EAM) exceptionally difficult. Identifying critical isthmuses—the narrow corridors of viable myocardium that support reentrant circuits—is often akin to finding a needle in a haystack. The CORECA study (Impact of Congenital Substrate 3D Imaging Reconstruction to Guide VT Catheter Ablation) sought to determine if preprocedural 3D imaging could provide a roadmap to simplify these procedures and improve outcomes.
Highlights of the CORECA Study
The CORECA study provides several pivotal insights into the integration of advanced imaging in the electrophysiology lab:
- High Concordance: Preprocedural 3D imaging identified VT substrates in 87.5% concordance with invasive electroanatomical mapping.
- Diagnostic Accuracy: The imaging-based approach demonstrated a sensitivity of 87.0% and a positive predictive value of 77.0% for identifying critical isthmuses.
- Reproducibility: There was a high degree of interobserver agreement among electrophysiologists using the software, suggesting the technology is reliable across different operators.
- Clinical Success: The use of these anatomical roadmaps supported an acute ablation success rate of 92.5% in a highly complex patient cohort.
Study Design and Methodology
The CORECA study was a multicenter, prospective investigation involving five specialized congenital electrophysiology centers. It included 40 consecutive patients (mean age 38±12 years, 67.5% male) referred for VT ablation. The cohort represented a spectrum of complex CHD, including patients with a history of spontaneous sustained VT (70%).
Preprocedural Imaging and Reconstruction
All patients underwent high-resolution cardiac computed tomography (CT) or magnetic resonance imaging (MRI) prior to the procedure. These images were processed using dedicated software (InHeart) to create 3D anatomic and substrate reconstructions. This software allows for the identification of myocardial thinning and structural features that correlate with slow conduction zones and reentrant circuits.
Blinded Annotation and Validation
A rigorous methodological approach was employed to test the reliability of the imaging. Three independent electrophysiologists, blinded to each other and to the actual ablation procedure, annotated potential ablation targets on the 3D reconstructions. These annotations were then compared against the gold-standard electroanatomical mapping generated during the actual clinical procedure. The primary endpoints were the sensitivity, positive predictive value, and interobserver reproducibility of the imaging-based targets.
Key Findings: Bridging the Gap Between Imaging and Anatomy
The results of the CORECA study underscore the potential for imaging to shift VT ablation from a purely discovery-based procedure to a more targeted, planned intervention.
Efficacy in Identifying VT Substrates
The study found that VT was inducible in nearly all patients (97.5%), highlighting the high arrhythmic burden of the cohort. The preprocedural imaging successfully identified the VT substrate in 87.5% of cases. When analyzing the specific anatomical isthmuses—the targets of ablation—the imaging showed an 87.0% sensitivity. This suggests that the vast majority of critical reentrant circuits can be visualized before the patient even enters the electrophysiology lab.
Interobserver Reproducibility
One of the most encouraging findings was the consistency between operators. Complete agreement between all three observers was achieved in 65.0% of cases, with moderate agreement in another 22.5%. Poor agreement was noted in only 5.0% of cases. This high level of reproducibility is essential for clinical adoption, as it suggests that the identification of targets is not overly dependent on the specific expertise of a single individual but is supported by the clarity of the reconstructed data.
Acute Procedural Outcomes
The integration of imaging data likely contributed to the high acute success rate of 92.5%. By providing a clear visualization of surgical patches, conduits, and areas of myocardial fibrosis, the 3D models allowed operators to navigate complex intracardiac environments with greater precision. This is particularly relevant in CHD patients where standard anatomical landmarks are often distorted or absent.
Expert Commentary: A Paradigm Shift in Complex Ablation
The CORECA study addresses a major unmet need in adult congenital heart disease. Traditionally, VT ablation in this population required extensive and time-consuming activation and entrainment mapping, which is often limited by the hemodynamic instability of the patient during tachycardia. The move toward a substrate-based approach, guided by anatomy, represents a significant evolution.
Mechanistic Insights
The study reinforces the concept that in CHD, VT is primarily macro-reentrant and determined by fixed anatomical barriers. Unlike ischemic VT, where the scar can be diffuse and dynamic, CHD-related VT often relies on well-defined ‘isthmuses’ between surgical scars and non-conductive anatomical structures (like the tricuspid annulus or pulmonary artery). The 3D reconstructions are particularly adept at highlighting these fixed corridors.
Limitations and Future Directions
While the results are promising, the study is limited by its relatively small sample size (n=40), which is common in CHD research due to the heterogeneity of the population. Furthermore, while the acute success rate was high, long-term follow-up data is needed to determine if imaging-guided ablation reduces VT recurrence over months and years. Future studies should also investigate whether this approach can significantly reduce procedural time and fluoroscopy exposure, which would be a major benefit for these often young and multi-operated patients.
Conclusion: The Future of Guided Electrophysiology
The CORECA study demonstrates that 3D anatomic and substrate reconstruction is a powerful tool for the management of VT in complex congenital heart disease. By reliably identifying critical isthmuses with high reproducibility, this technology allows for a more personalized and precise approach to ablation. As the population of adults with CHD continues to grow, integrating advanced imaging into the electrophysiology workflow will likely become standard practice, transforming how we treat these challenging patients and improving their long-term cardiovascular outcomes.
References
1. Bessiere F, et al. Impact of Congenital Substrate 3D Imaging Reconstruction to Guide VT Catheter Ablation: The CORECA Study. Circ Arrhythm Electrophysiol. 2026 Feb;19(2):e014034. doi: 10.1161/CIRCEP.125.014034.
2. Khairy P, et al. Ventricular arrhythmias and sudden cardiac death in adults with congenital heart disease. Circulation. 2014;129(18):1841-1851.
3. Zeppenfeld K, et al. Ventricular tachycardia in patients with repaired tetralogy of Fallot: the Role of Anatomic Isthmuses. J Am Coll Cardiol. 2007;49(14):1548-1556.
